The impact of gender and peripheral blood parameters on the characteristics of L-PRF membranes.

[1]  A. Alibrandi,et al.  Periodontitis activates the nlrp3 inflammasome in serum and saliva. , 2021, Journal of periodontology.

[2]  Yan Lin,et al.  Platelet-rich fibrin and concentrated growth factors as novel platelet concentrates for chronic hard-to-heal skin ulcers: a systematic review and Meta-analysis of randomized controlled trials , 2020, The Journal of dermatological treatment.

[3]  M. Quirynen,et al.  Mechanical and structural properties of leukocyte- and platelet-rich fibrin membranes: An in vitro study on the impact of anticoagulant therapy. , 2020, Journal of periodontal research.

[4]  A. Giudice,et al.  Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review. , 2020, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[5]  R. Rai,et al.  Comparison of Efficacy of Autologous Platelet-Rich Fibrin versus Unna's Paste Dressing in Chronic Venous Leg Ulcers: A Comparative Study , 2020, Indian dermatology online journal.

[6]  J. Zhao,et al.  Effect of autogenous growth factors released from platelet concentrates on the osteogenic differentiation of periodontal ligament fibroblasts: a comparative study , 2019, PeerJ.

[7]  S. Hasannia,et al.  Platelet‐rich fibrin elicits an anti‐inflammatory response in macrophages in vitro , 2019, Journal of periodontology.

[8]  Dongmei Zhang,et al.  Effect of platelet-rich fibrin on alveolar ridge preservation: A systematic review. , 2019, Journal of the American Dental Association.

[9]  R. Pakhmode,et al.  Coronally advanced flap with and without platelet-rich fibrin in the treatment of multiple adjacent recession defects: A randomized controlled split-mouth trial , 2019, Journal of Indian Society of Periodontology.

[10]  Juan Xie,et al.  Platelet-rich fibrin as an alternative adjunct to tendon-exposed wound healing: A randomized controlled clinical trial. , 2019, Burns : journal of the International Society for Burn Injuries.

[11]  W. Teughels,et al.  Simultaneous sinus floor elevation and implant placement using leukocyte- and platelet-rich fibrin as a sole graft material. , 2019, The International journal of oral & maxillofacial implants.

[12]  K. Ozer,et al.  Leucocyte- and platelet-rich fibrin as a rescue therapy for small-to-medium-sized complex wounds of the lower extremities , 2019, Burns & Trauma.

[13]  W. Teughels,et al.  Characterization of the Leukocyte- and Platelet-Rich Fibrin Block: Release of Growth Factors, Cellular Content, and Structure. , 2019, The International journal of oral & maxillofacial implants.

[14]  K. Vinay,et al.  Platelet-rich fibrin dressings in treating nonhealing leg ulcers. , 2019, Journal of the American Academy of Dermatology.

[15]  M. Quirynen,et al.  Angiogenic Properties of ‘Leukocyte- and Platelet-Rich Fibrin’ , 2018, Scientific Reports.

[16]  W. Teughels,et al.  L‐PRF for increasing the width of keratinized mucosa around implants: A split‐mouth, randomized, controlled pilot clinical trial , 2018, Journal of periodontal research.

[17]  W. Chan,et al.  Relationships of Age and Sex with Cytokine Content and Distribution in Human Platelet Fibrin Gels , 2018, Scientific Reports.

[18]  M. Crisci,et al.  Platelet-Rich Concentrates (L-PRF, PRP) in Tissue Regeneration: Control of Apoptosis and Interactions with Regenerative Cells , 2018 .

[19]  Asser A Goda,et al.  Autogenous leucocyte-rich and platelet-rich fibrin for the treatment of leg venous ulcer: a randomized control study , 2018 .

[20]  M. Quirynen,et al.  Leucocyte- and platelet-rich fibrin (L-PRF) as a regenerative medicine strategy for the treatment of refractory leg ulcers: a prospective cohort study , 2018, Platelets.

[21]  M. Quirynen,et al.  Leucocyte‐ and platelet‐rich fibrin block for bone augmentation procedure: A proof‐of‐concept study , 2018, Journal of clinical periodontology.

[22]  M. Quirynen,et al.  The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane , 2018, Platelets.

[23]  W. Robinson,et al.  Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma , 2018, The American journal of sports medicine.

[24]  A. Pradeep,et al.  Platelet‐Rich Fibrin Combined With a Porous Hydroxyapatite Graft for the Treatment of 3‐Wall Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial , 2017, Journal of periodontology.

[25]  A. Pradeep,et al.  Autologous Platelet‐Rich Fibrin in the Treatment of 3‐Wall Intrabony Defects in Aggressive Periodontitis: A Randomized Controlled Clinical Trial , 2017, Journal of periodontology.

[26]  N. Morrell,et al.  Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2 , 2017, The Journal of Biological Chemistry.

[27]  N. Ferlazzo,et al.  Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer , 2017, International journal of molecular sciences.

[28]  W. Teughels,et al.  Regenerative potential of leucocyte‐ and platelet‐rich fibrin. Part A: intra‐bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta‐analysis , 2016, Journal of clinical periodontology.

[29]  Sridhar,et al.  AUTOLOGOUS PLATELET RICH PLASMA (PRP) VERSUS LEUCOCYTE-PLATELET RICH FIBRIN (L-PRF) IN CHRONIC NON-HEALING LEG ULCERS - A RANDOMISED, OPEN LABELLED, COMPARATIVE STUDY , 2016 .

[30]  S. Singhal,et al.  Platelet-Rich Fibrin With 1.2% Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial. , 2016, Journal of periodontology.

[31]  P. Madurantakam,et al.  Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial. , 2015, Journal of visualized experiments : JoVE.

[32]  R. Ientile,et al.  Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages , 2015, Amino Acids.

[33]  A. Pradeep,et al.  Platelet-rich fibrin with 1% metformin for the treatment of intrabony defects in chronic periodontitis: a randomized controlled clinical trial. , 2015, Journal of periodontology.

[34]  S. Kohl,et al.  Platelet-rich Concentrates Differentially Release Growth Factors and Induce Cell Migration In Vitro , 2015, Clinical orthopaedics and related research.

[35]  C. Patterson,et al.  The role of BMPs in endothelial cell function and dysfunction , 2014, Trends in Endocrinology & Metabolism.

[36]  R. Topolski,et al.  Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. , 2014, Military medicine.

[37]  A. Pradeep,et al.  Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial. , 2013, Journal of periodontal research.

[38]  O. Rouaud,et al.  Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population‐based study (the Three‐City cohort study) , 2012, Clinical endocrinology.

[39]  W. Sami,et al.  Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[40]  J. Price,et al.  Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers. , 2012, The Journal of clinical endocrinology and metabolism.

[41]  P. Boileau,et al.  Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions. , 2012, Current pharmaceutical biotechnology.

[42]  D. M. Dohan Ehrenfest,et al.  Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). , 2012, Current pharmaceutical biotechnology.

[43]  D. M. Dohan Ehrenfest,et al.  Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. , 2010, Journal of periodontology.

[44]  Ye Lin,et al.  A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[45]  R. Flaumenhaft,et al.  Platelet alpha-granules: basic biology and clinical correlates. , 2009, Blood reviews.

[46]  A. Dohan,et al.  Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[47]  A. Dohan,et al.  Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[48]  G. Hafner,et al.  Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[49]  H. Vorster,et al.  Plasma fibrinogen of black South Africans: the BRISK study , 1998, Public Health Nutrition.

[50]  C. Ashworth,et al.  Blood Specific Gravity Studies. Relationship of Specific Gravity of Whole Blood to Specific Gravity of Plasma, Red Blood Cell Count, Hematoerit, and Hemoglobin as Indicators of Hemoeoncentration. , 1941 .